Long–term protection against SIV–induced disease in macaques vaccinated with a live attenuated HIV–2 vaccine

Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 Infection

1995 • 1,044 citations

Protective Effects of a Live Attenuated SIV Vaccine with a Deletion in the nef Gene

1992 • 1,025 citations

An African primate lentivirus (SIVsmclosely related to HIV-2

1989 • 750 citations

Studies in Subjects with Long-Term Nonprogressive Human Immunodeficiency Virus Infection

1995 • 750 citations

Human infection by genetically diverse SIVSM-related HIV-2 in West Africa

1992 • 496 citations

Pathogenicity of Live, Attenuated SIV After Mucosal Infection of Neonatal Macaques

1995 • 491 citations

Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology

1994 • 351 citations

Simple, sensitive, and specific detection of human immunodeficiency virus type 1 in clinical specimens by polymerase chain reaction with nested primers

1990 • 256 citations

Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys

1991 • 202 citations

Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV

1990 • 136 citations

Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals

1990 • 131 citations

A New Human Retrovirus Isolate of West African Origin (SBL-6669) and Its Relationship to HTLV-IV, LAV-II, and HTLV-IIIB

1987 • 123 citations

The immunological principles of vaccination

1990 • 108 citations

Infection of cynomolgus monkeys with HIV-2 protects against pathogenic consequences of a subsequent simian immunodeficiency virus infection

1990 • 73 citations

Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines

1994 • 64 citations

Reduced Virus Load in Rhesus Macaques Immunized with Recombinant gp160 and Challenged with Simian Immunodeficiency Virus

1994 • 64 citations

Experimental infection of cynomolgus monkeys (Macaca fascicularis) with HIV-2.

1989 • 60 citations

Clinical features and predictive markers of disease progression in cynomolgus monkeys experimentally infected with simian immunodeficiency virus

1992 • 55 citations

Prolonged Clinical Latency and Survival of Macaques Given a Whole Inactivated Simian Immunodeficiency Virus Vaccine

1994 • 44 citations

Experimental infection of cynomolgus monkeys (Macaca fascicularis) with simian immunodeficiency virus (SIVsm).

1989 • 42 citations

Cross-Neutralizing Antibodies Against HIV-1 (HTLV-IIIB and HTLV-IIIRF) and HIV-2 (SBL-6669 and a New Isolate SBL-K135)

1989 • 19 citations

Prospects for an HIV‐vaccine

1991 • 19 citations

Prevention of transmission of simian immunodeficiency virus from vaccinated macaques that developed transient virus infection following challenge

1993 • 15 citations

Stable Biological and Antigenic Characteristics of HIV-2SBL6669 in Nonpathogenic Infection of Macaques

1994 • 11 citations